AstraZeneca results, rate cut bets power FTSE 100
FTSE 100 hits record high ahead of expected interest rate cut
Most sectors in the FTSE 100 were up, boosted by strong corporate earnings. AstraZeneca, the FTSE 100’s most valuable company, rose 4.8 per cent following better than expected results. Shares in Babcock, an engineering outsourcer, rose as much as 11 per cent after it upgraded its outlook.
By Atsuhito Mori, Head of Sustainable Investment, Japan, FTSE Russell. FTSE Blossom is FTSE Russell's flagship sustainable ...
This article looks at the FTSE 100 index and what to expect next week as several blue chip companies like Barclays and ...
The FTSE 100 has started the year with a bang, hitting its second all-time high of 2025 on Thursday morning, surging past ...
Governor Andrew Bailey says the BOE will take a “gradual and careful” approach to cutting rates Join the Markets Today team - ...
Harvey Jones loves his FTSE 100 dividend income shares but was disappointed by the lack of growth. Now it looks like that may ...
Explore the factors behind the FTSE 100's record high, including corporate earnings, interest rate expectations, and sector ...
London's blue-chip index jumped to a record high on Thursday, lifted by shares of AstraZeneca after upbeat results and ahead ...
GSK shares lead the FTSE 100 after it raised its growth guidance and announced a share buyback Join the Markets Today team -- ...
The FTSE 100 headed lower as trading got underway on Friday, in line with a drop for heavyweights AstraZeneca PLC (LON: AZN) ...
FTSE AIM stock Jet2 appears to be a bargain in plain sight. I’m desperately searching for reasons not to buy this stock, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback